BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 21453240)

  • 1. Bioactive sphingolipids in response to chemotherapy: a scope on leukemias.
    Ekiz HA; Baran Y
    Anticancer Agents Med Chem; 2011 May; 11(4):385-97. PubMed ID: 21453240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel agents targeting bioactive sphingolipids for the treatment of cancer.
    Adan-Gokbulut A; Kartal-Yandim M; Iskender G; Baran Y
    Curr Med Chem; 2013; 20(1):108-22. PubMed ID: 23244584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic applications of bioactive sphingolipids in hematological malignancies.
    Ekiz HA; Baran Y
    Int J Cancer; 2010 Oct; 127(7):1497-506. PubMed ID: 20503271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolism and biological functions of two phosphorylated sphingolipids, sphingosine 1-phosphate and ceramide 1-phosphate.
    Kihara A; Mitsutake S; Mizutani Y; Igarashi Y
    Prog Lipid Res; 2007 Mar; 46(2):126-44. PubMed ID: 17449104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Sphingolipid Mediators on the Determination of Cochlear Survival in Ototoxicity.
    Tabuchi K; Hara A
    Curr Mol Pharmacol; 2018; 11(4):279-284. PubMed ID: 29766830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of bioactive sphingolipids in 4-HPR-resistant leukemia cells.
    Apraiz A; Idkowiak-Baldys JK; Boyano MD; Pérez-Yarza G; Hannun YA; Asumendi A
    BMC Cancer; 2011 Nov; 11():477. PubMed ID: 22061047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sphingolipid metabolism in cancer signalling and therapy.
    Ogretmen B
    Nat Rev Cancer; 2018 Jan; 18(1):33-50. PubMed ID: 29147025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer and sphingolipid storage disease therapy using novel synthetic analogs of sphingolipids.
    Gatt S; Dagan A
    Chem Phys Lipids; 2012 May; 165(4):462-74. PubMed ID: 22387097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel mechanisms of action of classical chemotherapeutic agents on sphingolipid pathways.
    Hajj C; Becker-Flegler KA; Haimovitz-Friedman A
    Biol Chem; 2015 Jun; 396(6-7):669-79. PubMed ID: 25719313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthetic, non-natural sphingolipid analogs inhibit the biosynthesis of cellular sphingolipids, elevate ceramide and induce apoptotic cell death.
    Dagan A; Wang C; Fibach E; Gatt S
    Biochim Biophys Acta; 2003 Sep; 1633(3):161-9. PubMed ID: 14499735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sphingolipid metabolism and leukemia: a potential for novel therapeutic approaches.
    Burns TA; Luberto C
    Anticancer Agents Med Chem; 2011 Nov; 11(9):863-81. PubMed ID: 21707485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disruption of sphingolipid metabolism augments ceramide-induced autophagy in preeclampsia.
    Melland-Smith M; Ermini L; Chauvin S; Craig-Barnes H; Tagliaferro A; Todros T; Post M; Caniggia I
    Autophagy; 2015 Apr; 11(4):653-69. PubMed ID: 25853898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Roles of bioactive sphingolipids in cancer biology and therapeutics.
    Saddoughi SA; Song P; Ogretmen B
    Subcell Biochem; 2008; 49():413-40. PubMed ID: 18751921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sphingolipid metabolic changes during chiral C2-ceramides induced apoptosis in human leukemia cells.
    Baek MY; Yoo HS; Nakaya K; Moon DC; Lee YM
    Arch Pharm Res; 2001 Apr; 24(2):144-9. PubMed ID: 11339634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolomic profiling of sphingolipids in human glioma cell lines by liquid chromatography tandem mass spectrometry.
    Sullards MC; Wang E; Peng Q; Merrill AH
    Cell Mol Biol (Noisy-le-grand); 2003 Jul; 49(5):789-97. PubMed ID: 14528916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ceramide Metabolism Enzymes-Therapeutic Targets against Cancer.
    Gomez-Larrauri A; Das Adhikari U; Aramburu-Nuñez M; Custodia A; Ouro A
    Medicina (Kaunas); 2021 Jul; 57(7):. PubMed ID: 34357010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Cross-Talk Between Sphingolipids and Insulin-Like Growth Factor Signaling: Significance for Aging and Neurodegeneration.
    Jęśko H; Stępień A; Lukiw WJ; Strosznajder RP
    Mol Neurobiol; 2019 May; 56(5):3501-3521. PubMed ID: 30140974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological modulation of sphingolipids and role in disease and cancer cell biology.
    Morales A; Fernandez-Checa JC
    Mini Rev Med Chem; 2007 Apr; 7(4):371-82. PubMed ID: 17430223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel mechanism of dasatinib-induced apoptosis in chronic myeloid leukemia; ceramide synthase and ceramide clearance genes.
    Gencer EB; Ural AU; Avcu F; Baran Y
    Ann Hematol; 2011 Nov; 90(11):1265-75. PubMed ID: 21455605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sphingosine-1-phosphate phosphohydrolase in regulation of sphingolipid metabolism and apoptosis.
    Le Stunff H; Galve-Roperh I; Peterson C; Milstien S; Spiegel S
    J Cell Biol; 2002 Sep; 158(6):1039-49. PubMed ID: 12235122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.